Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 1.00 |
| ▸ | RAB9A | P51151 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | GRIN2D | O15399 | 3/20 | 0.64 |
| ▸ | GRIN3B | O60391 | 3/20 | 0.64 |
| ▸ | GRIN1 | Q05586 | 3/20 | 0.64 |
| ▸ | GRIN2A | Q12879 | 3/20 | 0.64 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.64 |
| ▸ | GRIN2C | Q14957 | 3/20 | 0.64 |
| ▸ | GRIN3A | Q8TCU5 | 3/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | CASP3 | P42574 | 1/20 | 0.52 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.52 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.52 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | RRM1 | P23921 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2608307 | 1.00 | NPC1 (1.00) | NPC1RAB9ASMN1; SMN2GRIN2DGRIN3B | |
| SCHEMBL7793323 | 0.88 | NPC1 (0.77) | NPC1RAB9ASMN1; SMN2GRIN2DGRIN3B | |
| SCHEMBL7793321 | 0.88 | NPC1 (0.77) | NPC1RAB9ASMN1; SMN2GRIN2DGRIN3B | |
| SCHEMBL19036447 | 0.88 | NPC1 (0.77) | NPC1RAB9ASMN1; SMN2GRIN2DGRIN3B | |
| SCHEMBL10942218 | 0.86 | NPC1 (0.74) | NPC1RAB9ASMN1; SMN2GRIN2DGRIN3B | |
| SCHEMBL22995747 | 0.84 | NPC1 (0.71) | NPC1RAB9ASMN1; SMN2GRIN2DGRIN3B | |
| SCHEMBL22198249 | 0.84 | SMN1; SMN2 (0.71) | NPC1RAB9ASMN1; SMN2GRIN2DGRIN3B | |
| SCHEMBL22198250 | 0.84 | NPC1 (0.71) | NPC1RAB9ASMN1; SMN2GRIN2DGRIN3B | |
| SCHEMBL7793269 | 0.82 | NPC1 (0.68) | NPC1RAB9ASMN1; SMN2GRIN2DGRIN3B | |
| SCHEMBL7793264 | 0.82 | NPC1 (0.68) | NPC1RAB9ASMN1; SMN2GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4015014-A | Method for the use of aryl azines as anthelmintics | THE DOW CHEMICAL COMPANY (US) | 1977-03-29 | — | — | US | claimed |
| US-7947802-B2 | Benzoxazine monomers, polymers and compositions | CASE WESTERN RESERVE UNIVERSITY (US) | 2011-05-24 | — | — | US | disclosed |
| US-20090069533-A1 | Benzoxazine monomers, polymers and compositions | CASE WESTERN RESERVE UNIVERSITY | 2009-03-12 | — | — | US | disclosed |
| US-4015014-A | Method for the use of aryl azines as anthelmintics | THE DOW CHEMICAL COMPANY (US) | 1977-03-29 | — | — | US | disclosed |
| US-3939147-A | Novel 1,2-diaza-1,5,9-cyclo dodecatrienes and 1,2-diaza-1-cyclododecenes | CIBA-GEIGY CORPORATION (US) | 1976-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069533-A1 | Benzoxazine monomers, polymers and compositions | MUS81, DDX42, BRAP | NPC1 4884/4885RAB9A 4809/4885SMN1; SMN2 2004/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.